Kymriah Европейски съюз - български - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Други антинеопластични средства - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

ADVANTAGE spot on for large cats and pet rabbits 100 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

advantage spot on for large cats and pet rabbits 100 mg/ml

elanco animal health gmbh - Имидаклоприд - течност за прилагане върху ограничен участък - 100 mg/ml - зайци, котки

Prinocate 400 mg/100 mg spot-on solution for extra-large dogs България - български - БАБХ (Българска агенция по безопасност на храните)

prinocate 400 mg/100 mg spot-on solution for extra-large dogs

krka, d.d. - Имидаклоприд, Моксидектин - разтвор за прилагане върху ограничен участък - 400 mg/4 ml; 100 mg/ 4 ml - кучета

Breyanzi Европейски съюз - български - EMA (European Medicines Agency)

breyanzi

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - Антинеопластични средства - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Zynlonta Европейски съюз - български - EMA (European Medicines Agency)

zynlonta

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - Антинеопластични средства - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Tepkinly Европейски съюз - български - EMA (European Medicines Agency)

tepkinly

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - Антинеопластични средства - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.